These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7035640)

  • 1. Dosing implications of altered gentamicin disposition in patients with cystic fibrosis.
    Kearns GL; Hilman BC; Wilson JT
    J Pediatr; 1982 Feb; 100(2):312-8. PubMed ID: 7035640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis.
    Mann HJ; Canafax DM; Cipolle RJ; Daniels CE; Zaske DE; Warwick WJ
    Pediatr Pulmonol; 1985; 1(5):238-43. PubMed ID: 4069813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis.
    Bauer LA; Piecoro JJ; Wilson HD; Blouin RA
    Clin Pharm; 1983; 2(3):262-4. PubMed ID: 6883955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study.
    Levy J; Smith AL; Koup JR; Williams-Warren J; Ramsey B
    J Pediatr; 1984 Jul; 105(1):117-24. PubMed ID: 6376743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.
    McDade EJ; Wagner JL; Moffett BS; Palazzi DL
    Pharmacotherapy; 2010 Mar; 30(3):248-53. PubMed ID: 20180608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualizing gentamicin dosage in patients with cystic fibrosis: limitations to pharmacokinetic approach.
    Hendeles L; Iafrate RP; Stillwell PC; Mangos JA
    J Pediatr; 1987 Feb; 110(2):303-10. PubMed ID: 3806307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal clearance of gentamicin in cystic fibrosis.
    MacDonald NE; Anas NG; Peterson RG; Schwartz RH; Brooks JG; Powell KR
    J Pediatr; 1983 Dec; 103(6):985-90. PubMed ID: 6644440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentamicin disposition in young and elderly patients with various degrees of renal function.
    Matzke GR; Jameson JJ; Halstenson CE
    J Clin Pharmacol; 1987 Mar; 27(3):216-20. PubMed ID: 3680577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin disposition and effect on development of renal function in the very low birth weight infant.
    Landers S; Berry PL; Kearns GL; Kaplan SL; Rudolph AJ
    Dev Pharmacol Ther; 1984; 7(5):285-302. PubMed ID: 6383749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of single doses of gentamicin given by intravenous and intramuscular routes to lactating cows.
    Haddad NS; Ravis WR; Pedersoli WM; Carson RL
    Am J Vet Res; 1986 Apr; 47(4):808-13. PubMed ID: 3754403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of gentamicin in the juvenile dog.
    Riviere JE; Coppoc GL
    Am J Vet Res; 1981 Sep; 42(9):1621-3. PubMed ID: 7325472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tobramycin in cystic fibrosis.
    Kelly HB; Menendez R; Fan L; Murphy S
    J Pediatr; 1982 Feb; 100(2):318-21. PubMed ID: 7057342
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
    Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
    Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of gentamicin and dosing optimization for infants.
    Medellín-Garibay SE; Rueda-Naharro A; Peña-Cabia S; García B; Romano-Moreno S; Barcia E
    Antimicrob Agents Chemother; 2015 Jan; 59(1):482-9. PubMed ID: 25385111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromide pharmacokinetics in cystic fibrosis.
    Miller ME; Kornhauser DM
    Arch Pediatr Adolesc Med; 1994 Mar; 148(3):266-71. PubMed ID: 8130858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for dosing gentamicin in children and adolescents that adjusts for tissue accumulation with continuous dosing.
    Evans WE; Taylor RH; Feldman S; Crom WR; Rivera G; Yee GC
    Clin Pharmacokinet; 1980; 5(3):295-306. PubMed ID: 7389237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of gentamicin in children and adults.
    Siber GR; Echeverria P; Smith AL; Paisley JW; Smith DH
    J Infect Dis; 1975 Dec; 132(6):637-51. PubMed ID: 1202109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic model for gentamicin dosing with the use of individual patient parameters.
    Sawchuk RJ; Zaske DE; Cipolle RJ; Wargin WA; Strate RG
    Clin Pharmacol Ther; 1977 Mar; 21(3):362-9. PubMed ID: 837654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.